SNM means the continuous application of a short-pulse irritation current to a specific gill nerve by means of intervention, thus depriving the neurons of their own electrophysiological properties. Through electro-stimulation of the gill neurons and the inappropriate transmission of sensory signals, the bladder is under natural protective reflection. Anthropogenic agitation or inhibition of neural circuits; interference with abnormal arcs of gill neuroreflection; and, in turn, influence behaviour with organs that regulate the neurodynamic control of gills, such as bladders, urethropophagus and pelvis; act as “neuro-regulating” for the treatment of diseases of urinary road and pelvic functional disorders.
Adaptive and success rates of neurological adjustment
SNM treatment for bladder hyperactivity is 80% effective.
Oversurgery (Overactive bladder, OAB) is a group of symptoms at the heart of urination, accompanied or not accompanied by acute urine incontinence, usually accompanied by urine frequency and night urine. It is a collection characterized by an acute condition of urine; it is often accompanied by symptoms of urine frequency and night urine, which can be accompanied or not by acute urine incontinence; it can be shown in urine kinetics as an overexhaustion of urine muscles; it can also be other forms of urinary-vesicular dysfunction; and it is not identified as a cause of disease, which does not include symptoms caused by acute urinary tract infections or other forms of local changes in bladder urine.
77% success rate of non-obstructive urine retention treatment
Urinary Retention, UR: The urine is concentrated in the bladder, which is filled with urine and is not properly excreted, due to the reduced capacity of the bladder to autonomous discharge. Clinical characteristics include the difficulty of urinating, insinuation, waiting for urine, interruption of urine, with varying degrees of defecation, urination frequency, etc.
Patients with neurological control choose: persons who have successfully removed mechanical inhibition of the urination path but are unable to provide their own urine; lower limbs and vaginal motion and sensory functions are generally normal, and the arc of the cylindrical reflection is generally normal; they are partially self-repeated, with or without increased residual urine.
85% success rate of SNM treatment for incontinence
Symptoms of unconscious discharge through anal tubes of rectal content (septics, gas) or failure to effectively delay discharge. Common categories are: passive incontinence (intentional defecation); acute incontinence (subjective attempts to delay discharge but fail); and excreta leak (irregular defecation).
The SNM is an effective treatment for incontinent patients who have failed in conservative treatment and can be assessed for those who have been diagnosed as chronic incontinent & gt; six months (after & gt; 12 months after the delivery of the vagina), on average, & gt; two/weeks; and those who have failed in conservative treatment or are impatient.
70% success of IMV treatment
Pain on the cheekbone and in the bladder area, associated with the filling of the bladder, is accompanied by other symptoms: an increase in the number of daily or night urinary urinations, except for urinary tract infections and other visible pathologies, also known as bladder pain syndrome (BPS). The main characteristic is fibrosis of bladder walls, accompanied by reduced bladder capacity. Pains on the bladders during plethora, pains throughout the pelvis, including urine, vagina, vagina and rectum, and other genital parts, such as abdominal and back pains. Patients have a subjective feeling that the number of urinations is too high, with eight daily urinations, each of which is less than 200 ml; and more persistent impulses to urinate. For patients who are not ulcers, treatment has had a significant impact.
The neurogenic bladder success rate is 50%.
Diseases such as urination frequency, urination emergency, incontinence, erection disorders, constipation, sexual abnormalities, and delays or irregularities in treatment may cause complications such as urinary tract infections, kidneys and even kidney failure.
Patients must undergo a regular neurogenetic bladder screening and assessment before undergoing SNM treatment.
Patient selection: Uncompleted neuropsychological impairment, non-progressive neurological disorders, etc. Examples include: hidden hysteria, incomplete spinal cord damage, multiple sclerosis, etc.
SNM treatment is not recommended for patients with complete paraplegic, progressive nervous system pathologies, low-resistible bladders, retrenchment of bladders (class IV ~ V), urinary malignant neoplasms, etc.
50% – 70% success of chronic constipated treatment
Decreasing occurs in the form of reduced defecation, defecation and/or defecation difficulties; fewer defecation times: < 3 per week; defecation difficulties include heavy defecation, difficulty of excretion, insufficiency of defecation, time and handy-aided defecation; chronic constipation patients are often shown in reduced or unfeasible defecation, failure to defecate (air defecation), time for defecation and low daily defecation.
The SNM can transmit the nervous impulses to the central central neurological series of primary excretion, so that the spinal cord section can be introduced into neurodepolarization, irritating the cystals to facilitate the rebalancing and harmonization of the resonance of the gills, thus regulating the inner intestinal pressure, improving the intestinal and anal adhesive properties, increasing the frequency of gastrointestinal vibration, especially the wiping of the obituary, and promoting gastrointestinal emptiness.
In general, ecstasy management treatment is already a sharp instrument for patients with urinary disorders and has had a significant impact on the improvement of urination path symptoms. The success rate is, of course, closely linked to the choice of adaptive disease, which requires rigorous pre-operative control and evaluation.
